SCHEMBL18030939

SCHEMBL18030939

Cn1c2cc(C#N)ccc2c2cccc(C#N)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.39
▸ FTO Q9C0B1 1/20 0.39
▸ IMPDH2 P12268 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAOA P21397 3/20 0.37
▸ CDC7 O00311 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.35
▸ ENPP3 O14638 1/20 0.35
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ G6PD P11413 1/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ CREBBP Q92793 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ PTPN7 P35236 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18030969 0.88 EGFR (0.40) ALKBH5FTOIMPDH2L3MBTL1MEN1
SCHEMBL16441272 0.85 CASP3 (0.38) ALKBH5FTOL3MBTL1MEN1KMT2A
SCHEMBL18055746 0.85 ALKBH5 (0.42) ALKBH5FTOIMPDH2L3MBTL1KMT2A
SCHEMBL17032702 0.82 ALKBH5 (0.58) ALKBH5FTOIMPDH2L3MBTL1MEN1
SCHEMBL17034482 0.80 ALKBH5 (0.42) ALKBH5FTOIMPDH2L3MBTL1MAOA
SCHEMBL18030923 0.80 L3MBTL1 (0.41) L3MBTL1MEN1KMT2ACDC7CDK2
SCHEMBL18030921 0.80 IMPDH2 (0.46) ALKBH5FTOIMPDH2MAOACA1
SCHEMBL17032695 0.79 GPR3 (0.57) IMPDH2L3MBTL1MEN1KMT2ATLR9
SCHEMBL18030918 0.79 L3MBTL1 (0.40) IMPDH2L3MBTL1MEN1KMT2AMAOA
SCHEMBL18030960 0.78 L3MBTL1 (0.37) ALKBH5FTOIMPDH2L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3061759-B1 NITRILE SUBSTITUTED DIBENZOFURANS IDEMITSU KOSAN CO (JP) 2019-12-25 — — EP disclosed
EP-3119770-B1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES IDEMITSU KOSAN CO (JP) 2018-05-02 — — EP disclosed
US-20170098781-A1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES IDEMITSU KOSAN CO., LTD. (JP) 2017-04-06 — — US disclosed
US-20160248026-A1 NITRILE SUBSTITUTED DIBENZOFURANS IDEMITSU KOSAN CO., LTD. (JP) 2016-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170098781-A1 NEW DIBENZOFURANS AND DIBENZOTHIOPHENES DBF4, DDT, SLC43A3 ALKBH5 1111/4885FTO 509/4885IMPDH2 1250/4885
US-20160248026-A1 NITRILE SUBSTITUTED DIBENZOFURANS DBF4, NXF1, NCF1 ALKBH5 601/4885FTO 426/4885IMPDH2 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback